Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Swiss Pediatric Inflammatory Bain Disease Cohort Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05017142
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:03.030352+00:00
Published At
2024-12-16T00:00:00+00:00
Record Updated At
2024-12-16
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Optic Neuritis", "Transverse Myelitis", "Acute Disseminated Encephalomyelitis", "Multiple Sclerosis", "Neuromyelitis Optica Spectrum Disorder", "Anti-NMDAR Encephalitis", "Anti-GAD65 Associated Autoimmune Encephalitis", "Anti-AMPAR-1/2 Associated Autoimmune Encephalitis", "Anti-Lgi-1 Associated Autoimmune Encephalitis", "Anti-CASPR-2 Associated Autoimmune Encephalitis", "Anti-GABAR-1/2 Associated Autoimmune Encephalitis", "Onconeuronal Antibody (Hu, Ri, Yo, Amphiphysin, CRMP-5, Ma-1, Ma-2, SOX-1) Associated Autoimmune Encephalitis", "Hashimoto Encephalitis", "CNS Vasculitis", "CNS Sarcoidosis", "CNS Lupus", "Rasmussen Encephalitis", "Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-12-16"
protocolSection.identificationModule.nctId
"NCT05017142"
protocolSection.identificationModule.officialTitle
"Swiss Pediatric Inflammatory Bain Disease Cohort Study"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Optic Neuritis (protocolSection.conditionsModule.conditions)
  • Transverse Myelitis (protocolSection.conditionsModule.conditions)
  • Acute Disseminated Encephalomyelitis (protocolSection.conditionsModule.conditions)
  • Multiple Sclerosis (protocolSection.conditionsModule.conditions)
  • Neuromyelitis Optica Spectrum Disorder (protocolSection.conditionsModule.conditions)
  • Anti-NMDAR Encephalitis (protocolSection.conditionsModule.conditions)
  • Anti-GAD65 Associated Autoimmune Encephalitis (protocolSection.conditionsModule.conditions)
  • Anti-AMPAR-1/2 Associated Autoimmune Encephalitis (protocolSection.conditionsModule.conditions)
  • Anti-Lgi-1 Associated Autoimmune Encephalitis (protocolSection.conditionsModule.conditions)
  • Anti-CASPR-2 Associated Autoimmune Encephalitis (protocolSection.conditionsModule.conditions)
  • Anti-GABAR-1/2 Associated Autoimmune Encephalitis (protocolSection.conditionsModule.conditions)
  • Onconeuronal Antibody (Hu, Ri, Yo, Amphiphysin, CRMP-5, Ma-1, Ma-2, SOX-1) Associated Autoimmune Encephalitis (protocolSection.conditionsModule.conditions)
  • Hashimoto Encephalitis (protocolSection.conditionsModule.conditions)
  • CNS Vasculitis (protocolSection.conditionsModule.conditions)
  • CNS Sarcoidosis (protocolSection.conditionsModule.conditions)
  • CNS Lupus (protocolSection.conditionsModule.conditions)
  • Rasmussen Encephalitis (protocolSection.conditionsModule.conditions)
  • Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.